sorafenib has been researched along with Psoriasis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YY; Ensslin, CJ; Hsieh, CH; Hsieh, SY; Kao, PH; Kuo, TT; Miller, LS; Wu, MY; Yang, CH | 1 |
| Adachi, T; Aibiki, T; Hiraoka, A; Iwasaki, R; Izumoto, H; Michitaka, K; Miyata, H; Mori, K; Nagamatsu, K; Ninomiya, T; Okazaki, H; Okudaira, T; Suga, Y; Tsubouchi, E; Tsuruta, M; Yamago, H; Yoshino, T | 1 |
| Chubachi, S; Nakagawa, T | 1 |
| Ali, FR; Griffiths, CE; Yiu, ZZ | 1 |
| Fournier, C; Tisman, G | 1 |
| Chon, SY; Diamantis, ML | 1 |
| Dann, F; Kelly, K; Laquer, V; Saedi, N | 1 |
| Chiang, CP; Hung, CT; Wu, BY | 1 |
| Komine, M; Maekawa, T; Maki, N; Murata, S; Ohtsuki, M; Takatsuka, Y | 1 |
2 review(s) available for sorafenib and Psoriasis
| Article | Year |
|---|---|
Psoriasiform drug eruption secondary to sorafenib: case series and review of the literature.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Eruptions; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Psoriasis; Sorafenib | 2019 |
Paradoxical exacerbation of chronic plaque psoriasis by sorafenib.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Psoriasis; Sorafenib | 2016 |
7 other study(ies) available for sorafenib and Psoriasis
| Article | Year |
|---|---|
Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Psoriasis; Sorafenib; Treatment Outcome | 2020 |
[A Case of Wilson's Disease with Psoriasis Vulgaris, Complicated with Hepatocellular Carcinoma and Successfully Treated with Sorafenib].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatolenticular Degeneration; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Psoriasis; Recurrence; Sorafenib | 2015 |
Sorafenib-associated remission of psoriasis in hypernephroma: case report.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Psoriasis; Pyridines; Pyrroles; Retreatment; Sorafenib; Sunitinib; Treatment Outcome | 2010 |
Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Psoriasis; Pyridines; Sorafenib; Thyroid Neoplasms | 2010 |
Sorafenib-associated psoriasiform skin changes.
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Hand; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Psoriasis; Pyridines; Sorafenib | 2010 |
Sorafenib-induced psoriasis and hand-foot skin reaction responded dramatically to systemic narrowband ultraviolet B phototherapy.
Topics: Antineoplastic Agents; Hand-Foot Syndrome; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Psoriasis; Sorafenib; Ultraviolet Therapy | 2012 |
Pustular eruption induced by sorafenib in a case of psoriasis vulgaris.
Topics: Aged; Asian People; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Psoriasis; Severity of Illness Index; Skin Diseases, Vesiculobullous; Sorafenib | 2013 |